Physician profile
Nurilign Bulcha
NPI 1811309511
$9,417.02
in general payments reported to CMS, 2019-2025
17 companies · $1,803 in 2025
The $1,803 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.30 · 2022: $299 · 2023: $7,295 · 2025: $1,803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,143 · Food and Beverage: $3,764 · Education: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,142.99 |
| Food and Beverage | $3,763.50 |
| Education | $192.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,075.44 | 2021-2023 | Turbohawk, Corevalve Evolut R, Onyx Frontier |
| Abbott Laboratories | $1,928.55 | 2023-2025 | Perclose Proglide, Mitraclip, Diamondback Coronary |
| W. L. Gore & Associates, INC. | $1,773.28 | 2023 | Gore Cardioform Septal Occluder, Gore-Tex Stretch Vascular Graft |
| Edwards Lifesciences Corporation | $1,412.30 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Inari Medical, INC. | $350.34 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $167.09 | 2023 | Impella |
| Cardiovascular Systems INC. | $148.00 | 2022 | |
| Boston Scientific Corporation | $128.64 | 2023 | Wolverine Coronary Cutting Balloon |
| Philips North America LLC | $94.34 | 2023 | |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Chiesi USA, INC. | $79.02 | 2022 | |
| Penumbra, INC. | $63.06 | 2023 | Indigo System |
| Bayer Healthcare Pharmaceuticals INC. | $25.99 | 2025 | |
| Amgen INC. | $25.16 | 2023 | Repatha |
| Lilly USA, LLC | $22.29 | 2025 | Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $21.87 | 2022 | |
| Scpharmaceuticals INC. | $17.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nurilign Bulcha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.